Consortium for Health and Military Performance, Department of Military and Emergency Medicine, F. Edward Hebert School of Medicine, Uniformed Services University, Bethesda, Maryland.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland.
JAMA Netw Open. 2022 Aug 1;5(8):e2226040. doi: 10.1001/jamanetworkopen.2022.26040.
Cold, flu, and immunity dietary supplement product sales have skyrocketed since the start of the COVID-19 pandemic. Supporting or boosting the immune system has become an important reason for using dietary supplements, and many consumers are purchasing products through online platforms.
To examine whether select dietary supplement products advertised as supporting or boosting the immune system are accurately labeled according to the Supplement Facts label of listed ingredients and to qualitatively describe the product labels' characteristics in terms of claims made.
DESIGN, SETTING, AND PARTICIPANTS: In this case series, 30 featured immune health dietary supplements were selected and purchased from Amazon.com in May 2021. Product analysis was performed using liquid chromatography-mass spectrometry. The list of ingredients detected through analysis for each product was compared with the ingredients on the product's Supplement Facts label to determine whether the product's label was accurate. Claims made on product labels were also evaluated by using the Operation Supplement Safety Scorecard's set of questions to describe the labels' characteristics.
A total of 30 select dietary supplement products were evaluated. Thirteen of the 30 products had accurate labels based on the product analysis. Of the 17 products with inaccurate labels, 13 had ingredients listed on the labels that were not detected through analysis, such that their labels were misbranded. Nine products had substances detected that were not claimed on the product labels, some of which may be considered adulterated. Five were misbranded and contained additional components not claimed on the label. No product had third-party certification seals present on the packaging. Ten of the 13 products with accurate labels received a score of 4 or more when applying the Operation Supplement Safety Scorecard, meaning the product was "likely okay/less risky."
In this case series study, most of the products tested had inaccurate labels and claims that were inconsistent with requirements the US Food and Drug Administration has put forward for dietary supplements. Quality control measures seem to be insufficient for most of these select products, and claims made on labels may be misleading consumers who purchase products.
自 COVID-19 大流行开始以来,感冒、流感和免疫的膳食补充剂产品的销售额飙升。支持或增强免疫系统已成为使用膳食补充剂的一个重要原因,许多消费者通过在线平台购买产品。
检查宣传支持或增强免疫系统的某些膳食补充剂产品是否根据列出的成分的补充事实标签准确贴标,并从声称的角度定性描述产品标签的特征。
设计、设置和参与者:在本病例系列研究中,2021 年 5 月从亚马逊网站上选择并购买了 30 种特色免疫健康膳食补充剂。使用液相色谱-质谱法对产品进行分析。通过分析确定每个产品的成分清单与产品的补充事实标签上的成分进行比较,以确定产品标签是否准确。还使用操作补充安全记分卡的一套问题评估产品标签上的声称,以描述标签的特征。
共评估了 30 种特定的膳食补充剂产品。根据产品分析,30 种产品中有 13 种标签准确。在 17 种标签不准确的产品中,有 13 种产品的标签上列出的成分未通过分析检测到,因此其标签被误贴。9 种产品检测到未在产品标签上声称的物质,其中一些可能被视为掺假。5 种产品标签有误,含有标签上未声称的其他成分。没有产品在包装上有第三方认证印章。在应用操作补充安全记分卡时,13 种标签准确的产品中有 10 种得分为 4 分或更高,这意味着产品“可能是好的/风险较低”。
在本病例系列研究中,测试的大多数产品标签不准确,声称与美国食品和药物管理局为膳食补充剂提出的要求不一致。这些精选产品的大部分似乎缺乏质量控制措施,标签上的声称可能会误导购买产品的消费者。